Auxora for the Treatment of Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome

Microglial Calcium Waves During the Hyperacute Phase of Ischemic Stroke

Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial

The Orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis

CRAC Channels And Disease – From Human CRAC Channelopathies And Animal Models To Novel Drugs

Scroll to Top